VR Adviser, LLC Q2 2020 Filing
Filed August 14, 2020
Portfolio Value
$417.6B
Holdings
16
Report Date
Q2 2020
Filing Type
13F-HR
All Holdings (16 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | —CONSTELLATION PHARMACEUTICALS INC | 4,016,873 | $120.7B | 28.90% | |
| 2 | TREURTRILLIUM THERAPEUTICS INC | 6,790,000 | $54.9B | 13.15% | |
| 3 | ALTALTIMMUNE INC | 4,500,000 | $48.2B | 11.54% | |
| 4 | RLMDRELMADA THERAPEUTICS INC | 668,440 | $29.9B | 7.16% | |
| 5 | SURFUSDSURFACE ONCOLOGY INC | 3,877,895 | $25.4B | 6.09% | |
| 6 | KROSKEROS THERAPEUTICS INC | 672,306 | $25.2B | 6.04% | |
| 7 | VXRTVAXART INC | 2,765,000 | $24.5B | 5.86% | |
| 8 | —MYOVANT SCIENCES LTD | 845,000 | $17.4B | 4.17% | |
| 9 | —MARINUS PHARMACEUTICALS INC | 5,726,540 | $14.5B | 3.48% | |
| 10 | NARIUSDINARI MEDICAL INC | 235,000 | $11.4B | 2.73% | |
| 11 | KURAKURA ONCOLOGY INC | 575,000 | $9.4B | 2.24% | |
| 12 | SNDXSYNDAX PHARMACEUTICALS INC | 625,710 | $9.3B | 2.22% | |
| 13 | AVDLAVADEL PHARMACEUTICALS PLC | 1,057,827 | $8.5B | 2.05% | |
| 14 | ADAPYADAPTIMMUNE THERAPEUTICS | 781,940 | $7.8B | 1.87% | |
| 15 | ETNBGBP89BIO INC | 291,140 | $5.8B | 1.39% | |
| 16 | —SIERRA ONCOLOGY INC | 378,888 | $4.6B | 1.10% |